As we age, NAD+ levels naturally decline, leading to impaired cellular repair, reduced mitochondrial efficiency, and increased oxidative stress
Though the use of glutathione is mostly safe, individuals should be careful of some groups
Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high costsoften exceeding $1,000 per monthput them out of reach for many Americans whose insurance does not cover these medications
Based on prior trial data, how should we benchmark current obesity drugswhere is the bar set
Researchers should establish and document a fixed weekly injection day and approximate time of day for each study subject to facilitate steady-state pharmacokinetic modeling
So, why not IV Therapy a try